Medical practice patterns and socio-economic factors may explain geographical variation of end-stage renal disease incidence

Nephrology Dialysis Transplantation

Volumn 27, Issue 6, 2012, Pages 2312-2322

  Couchoud, Cécile ^a   Guihenneuc, Chantal ^b,c   Bayer, Florian ^d   Lemaitre, Vincent ^e   Brunet, Philippe ^f,g   Stengel, Bénédicte ^c,h  

^a AGENCE DE LA BIOMÉDECINE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^d Biomedicine Agency   (France)

^e CENTRE HOSPITALIER DE VALENCIENNES   (France)

^f AIX MARSEILLE UNIVERSITY   (France)

^g ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^h UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Diabetes; ESRD; RRT referral; Spatial analysis; Unemployment

Indexed keywords

ADULT; AGE; ARTICLE; COVARIANCE; DEATH; DIABETES MELLITUS; DIALYSIS; EARLY INTERVENTION; EPIDEMIOLOGICAL DATA; FRAIL ELDERLY; FRANCE; GENDER; GEOGRAPHICAL VARIATION; GLOMERULUS FILTRATION RATE; HEALTH CARE; HUMAN; INCIDENCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; NEPHROLOGIST; POPULATION DENSITY; PREVALENCE; PRIORITY JOURNAL; PRIVATE PRACTICE; REGISTER; RENAL REPLACEMENT THERAPY; SOCIOECONOMICS; UNEMPLOYMENT;

ADOLESCENT; ADULT; FEMALE; FOLLOW-UP STUDIES; GEOGRAPHY; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PROGNOSIS; REGISTRIES; RENAL REPLACEMENT THERAPY; SOCIOECONOMIC FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 84861889664     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr639     Document Type: Article

References (46)

1. ERA-EDTA Registry 2008 Annual Report. Amsterdam, The Netherlands: Academic Medical Center, Department of Medical Informatics, 2010
2. Caskey FJ, Kramer A, Elliott RF et al. Global variation in renal replacement therapy for end-stage renal disease. Nephrol Dial Transplant 2011; 26: 2604-2610
3. U S Renal Data System. USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, 2010
4. Couchoud C, Lassalle M, Stengel B et al. REIN Registry Annual Report 2009. Nephrol Ther 2011; 7(Suppl 2): S41-S214. http://www.agence-biomedecine.fr/ professionnels/le-programme-rein.html (12 November 2011, date last accessed)
5. McDonald S, McCredie M, Williams S et al. Factors influencing reported rates of treated end-stage renal disease. Adv Chronic Kidney Dis 2005; 12: 32-38
6. McClellan WM, Flanders WD. Risk factors for progressive chronic kidney disease. J Am Soc Nephrol 2003; 14: S65-S70
7. Levey AS, Stevens LA, Coresh J. Conceptual model of CKD: applications and implications. Am J Kidney Dis 2009; 53: S4-S16
8. Van Dijk PC, Jager KJ, Stengel B et al. Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000). Kidney Int 2005; 67: 1489-1499
9. Perneger TV, Brancati FL, Whelton PK et al. End-stage renal disease attributable to diabetes mellitus. Ann Intern Med 1994; 121: 912-918
10. Muntner P, Coresh J, Powe NR et al. The contribution of increased diabetes prevalence and improved myocardial infarction and stroke survival to the increase in treated end-stage renal disease. J Am Soc Nephrol 2003; 14: 1568-1577
11. Young EW, Mauger EA, Jiang KH et al. Socioeconomic status and endstage renal disease in the United States. Kidney Int 1994; 45: 907-911
12. Volkova N, McClellan W, Klein M et al. Neighborhood poverty and racial differences in ESRD incidence. J Am Soc Nephrol 2008; 19: 356-364
13. Ward MM. Socioeconomic status and the incidence of ESRD. Am J Kidney Dis 2008; 51: 563-572
14. Roderick P, Clements S, Stone N et al. What determines geographical variation in rates of acceptance onto renal replacement therapy in England? J Health Serv Res Policy 1999; 4: 139-146
15. Hommel K, Rasmussen S, Kamper AL et al. Regional and social inequalities in chronic renal replacement therapy in Denmark. Nephrol Dial Transplant 2010; 25: 2624-2632
16. Fan ZJ, Lackland DT, Lipsitz SR et al. Geographical patterns of end-stage renal disease incidence and risk factors in rural and urban areas of South Carolina. Health Place 2007; 13: 179-187
17. Hsu CY, Go AS, McCulloch CE et al. Exploring secular trends in the likelihood of receiving treatment for end-stage renal disease. Clin J Am Soc Nephrol 2007; 2: 81-88
18. Horl WH, de AF, Williams PF. Healthcare systems and end-stage renal disease (ESRD) therapies-an international review: access to ESRD treatments. Nephrol Dial Transplant 1999; 14 (Suppl 6): 10-15
19. Couchoud C, Guihenneuc C, Bayer F et al. The timing of dialysis initiation affects the incidence of renal replacement therapy. Nephrol Dial Transplant 2010; 25: 1576-1578
20. Arnold RM, Zeidel ML. Dialysis in frail elders-a role for palliative care. N Engl J Med 2009; 361: 1597-1598
21. Usami T, Koyama K, Takeuchi O et al. Regional variations in the incidence of end-stage renal failure in Japan. JAMA 2000; 284: 2622-2624
22. Caskey FJ, Schober-Halstenberg HJ, Roderick PJ et al. Exploring the differences in epidemiology of treated ESRD between Germany and England and Wales. Am J Kidney Dis 2006; 47: 445-454
23. Stewart JH, McCredie MR, Williams SM. Geographic, ethnic, agerelated and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002. Nephrol Dial Transplant 2006; 21: 2178-2183
24. Cass A, Cunningham J, Wang Z et al. Regional variation in the incidence of end-stage renal disease in Indigenous Australians. Med J Aust 2001; 175: 24-27
25. Goodchild MF, Janelle DG. Toward critical spatial thinking in the social sciences and humanities. GeoJournal 2010; 75: 3-13
26. Couchoud C, Stengel B, Landais P et al. The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France. Nephrol Dial Transplant 2006; 21: 411-418
27. Richardson S. Spatial models in epidemiological applications. In: Green PJ, Hjort NL, Richardson S (eds). Highly Structured Stochastic Systems. Oxford UK: Oxford University Press, 2010, pp. 237-259
28. Lawson A, Böhning D, Biggeri A. Disease Mapping and Risk Assessment for Public Health. Chichester, UK: John Wiley & Sons, 2010, pp. 3-13
29. Besag JE, York JC, Mollié A. Bayesian image restoration, with two applications in spatial statistics (with discussion). Ann Inst Stat Math 2010; 43: 1-59
30. Pascutto C, Wakefield JC, Best NG et al. Statistical issues in the analysis of disease mapping data. Stat Med 2000; 19: 2493-2519
31. Best N, Richardson S, Thomson A. A comparison of Bayesian spatial models for disease mapping. Stat Methods Med Res 2005; 14: 35-59
32. Tassone EC, Waller LA, Casper ML. Small-area racial disparity in stroke mortality: an application of bayesian spatial hierarchical modeling. Epidemiology 2009; 20: 234-241
33. Wakefield JC, Best NG, Waller LA. Bayesian approaches to disease mapping. In: Elliott P, Wakefield JC, Best NG, Briggs DJ (eds). Spatial Epidemiology: Methods and Applications. Oxford, UK: Oxford University Press, 2010, pp. 104-127
34. Lunn D, Thomas A, Best NG et al. WinBUGS-a Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput 2010; 10: 325-337
35. Kelsall J, Wakefield J. Discussion of 'Bayesian models for spatially correlated disease and exposure data', by Best et al. In: Bernardo JM, Berger JO, Dawid AP, Smith AFM, (eds). Bayesian Statistics 6. Oxford University Press, 2010, pp. 151
36. Maheswaran R, Haining RP, Pearson T et al. Outdoor NOx and stroke mortality: adjusting for small area level smoking prevalence using a Bayesian approach. Stat Methods Med Res 2006; 15: 499-516
37. Spiegelhalter DJ, Best NG, Carlin BP et al. Bayesian measures of model Complexity and fit (with discussion). J R Stat Soc Ser B 2010; 64: 583-616
38. Gelman A, Meng XL, Stern H. Posterior predictive assessment of model fitness via realized discrepancies. Stat Sin 2011; 6: 733-807
39. UK Renal Registry. The Thirteenth Annual Report, Bristol. 2010. http://www.renalreg.com/Reports/2010.html (10 November 2011, date last accessed)
40. Kondo N, Sembajwe G, Kawachi I et al. Income inequality, mortality, and self rated health: meta-analysis of multilevel studies. BMJ 2009; 339: b4471. doi: 10.1136/bmj.b4471
41. Hossain MP, Goyder EC, Rigby JE et al. CKD and poverty: a growing global challenge. Am J Kidney Dis 2009; 53: 166-174
42. Wild S, Macleod F, McKnight J et al. Impact of deprivation on cardiovascular risk factors in people with diabetes: an observational study. Diabet Med 2008; 25: 194-199
43. Fored CM, Ejerblad E, Fryzek JP et al. Socio-economic status and chronic renal failure: a population-based case-control study in Sweden. Nephrol Dial Transplant 2003; 18: 82-88
44. Maty SC, Everson-Rose SA, Haan MN et al. Education, income, occupation, and the 34-year incidence (1965-99) of Type 2 diabetes in the Alameda County Study. Int J Epidemiol 2005; 34: 1274-1281
45. Evans JM, Newton RW, Ruta DA et al. Socio-economic status, obesity and prevalence of Type 1 and Type 2 diabetes mellitus. Diabet Med 2000; 17: 478-480
46. Albert MA, Glynn RJ, Buring J et al. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events. Circulation 2006; 114: 2619-2626